Evidence map›Paper›PMID 29708041›Full record

ArticlePathogens and global health2018

Comparative analysis of Klebsiella pneumoniae strains isolated in 2012-2016 that differ by antibiotic resistance genes and virulence genes profiles.

Anastasia I Lev, Eugeny I Astashkin, Angelina A Kislichkina, Ekaterina V Solovieva, Tatiana I Kombarova, Olga V Korobova, Olga N Ershova, Irina A Alexandrova, Vladimir E Malikov, Alexander G Bogun and 4 more

Abstract read
In one paragraph

Article in Pathogens and global health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Carbapenemase-producing hypervirulentJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2026
    Article
  3. Article
  4. Article
  5. Comprehensive Genomic Characterization of a Drug-ResistantIranian journal of medical sciences · 2025
    Article
  6. Article
  7. Dissemination ofMicrobiology spectrum · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Effect of SiHuangQingXinWan onFrontiers in pharmacology · 2024
    Article
  16. Review
  17. A unique combination of natural fatty acids fromFrontiers in cellular and infection microbiology · 2024
    Article
  18. Review
  19. Article
  20. Molecular Epidemiology ofMicroorganisms · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Anastasia I Leva State Research Center for Applied Microbiology and Biotechnology , Obolensk , Russia.ORCID 0000-0002-0502-4218
Eugeny I Astashkina State Research Center for Applied Microbiology and Biotechnology , Obolensk , Russia.ORCID 0000-0002-3559-9071
Angelina A Kislichkinaa State Research Center for Applied Microbiology and Biotechnology , Obolensk , Russia.ORCID 0000-0001-8389-2494
Ekaterina V Solovievaa State Research Center for Applied Microbiology and Biotechnology , Obolensk , Russia.
Tatiana I Kombarovaa State Research Center for Applied Microbiology and Biotechnology , Obolensk , Russia.ORCID 0000-0003-1959-1739
Olga V Korobovaa State Research Center for Applied Microbiology and Biotechnology , Obolensk , Russia.ORCID 0000-0002-7068-3236
Olga N Ershovab Center for Neurosurgery (Academician Burdenko) , Moscow , Russia.
Irina A Alexandrovab Center for Neurosurgery (Academician Burdenko) , Moscow , Russia.
Vladimir E Malikovc Infectious Clinical Hospital No. 1 , Moscow , Russia.
Alexander G Boguna State Research Center for Applied Microbiology and Biotechnology , Obolensk , Russia.ORCID 0000-0001-5454-2495
Alexander I Borzilova State Research Center for Applied Microbiology and Biotechnology , Obolensk , Russia.
Nikolay V Volozhantseva State Research Center for Applied Microbiology and Biotechnology , Obolensk , Russia.ORCID 0000-0003-4667-1451
Edward A Svetocha State Research Center for Applied Microbiology and Biotechnology , Obolensk , Russia.ORCID 0000-0002-3185-1954
Nadezhda K Fursovaa State Research Center for Applied Microbiology and Biotechnology , Obolensk , Russia.ORCID 0000-0001-6053-2621

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antibacterial resistance and virulence genotypes and phenotypes of 148 non-duplicate Klebsiella pneumoniae strains collected from 112 patients in Moscow hospitals in 2012-2016 including isolates from the respiratory system (57%), urine (30%), wounds (5%), cerebrospinal fluid (4%), blood (3%), and rectal swab (1%) were determined. The majority (98%) were multidrug resistant (MDR) strains carrying bla

Indexed as

Drug Resistance, BacterialGenotypeAnimalsHospitalsHumansKlebsiella InfectionsKlebsiella pneumoniaeLethal Dose 50MiceMicrobial Sensitivity TestsMoscowVirulenceVirulence FactorsVirulence Factorsantibacterial resistanceKlebsiella pneumoniaeK-serotypeMLSTvirulence

Identifiers

PMID29708041
PMCPMC6056825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.